Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

KVB

K V Pharma CL B (KVB)

K V Pharma CL B
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:KVB
DateHeureSourceTitreSymboleSociété
18/06/201215h04Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVBK V Pharma CL B
17/11/201102h15Business WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
03/11/201102h40Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
01/11/201102h30Business WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
28/10/201122h30Business WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
24/10/201119h52Business WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
13/06/201114h00PR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVBK V Pharma CL B
01/04/201121h08Dow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVBK V Pharma CL B
01/04/201116h28Dow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVBK V Pharma CL B
31/03/201123h28Dow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVBK V Pharma CL B
30/03/201121h58Dow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
30/03/201118h38Dow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
01/03/201114h49PR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVBK V Pharma CL B
14/02/201116h34PR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVBK V Pharma CL B
14/02/201115h48PR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVBK V Pharma CL B
04/02/201114h40PR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVBK V Pharma CL B
12/01/201115h03PR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™NYSE:KVBK V Pharma CL B
14/09/201016h29Dow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVBK V Pharma CL B
10/09/201015h53Dow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVBK V Pharma CL B
20/01/201021h41Dow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVBK V Pharma CL B
20/01/201020h11Dow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVBK V Pharma CL B
11/01/201015h18PR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVB
07/01/201022h10PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVB
15/12/200923h26PR Newswire (US)KV Pharmaceutical Sets Record Date for Stockholder Action by Written ConsentNYSE:KVB
02/12/200922h45PR Newswire (US)KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van VlietNYSE:KVB
13/11/200922h01PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw AmendmentsNYSE:KVB
07/10/200919h54Dow Jones NewsLarge Generic Drug Cos Benefiting From Price StabilityNYSE:KVBK-V Pharmaceutical Co. (Cl B)
21/09/200914h30PR Newswire (US)KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)NYSE:KVB
15/09/200922h34PR Newswire (US)KV Pharmaceutical Receives Stockholder Action by Written ConsentNYSE:KVB
04/09/200923h43PR Newswire (US)KV Pharmaceutical Appoints Interim Chief Financial OfficerNYSE:KVB
 Showing the most relevant articles for your search:NYSE:KVB